In Nicaragua, the market size value for Penicillins and Streptomycins in dosage form experienced fluctuations from 2013 to 2023, reaching approximately 15.976 million USD in 2023. The market saw upward movements in 2014 and 2015, followed by declines until 2018. A slight recovery appeared from 2019 onwards, with the value peaking slightly again in 2021. Over the past five years, the Compound Annual Growth Rate (CAGR) averaged 0.75%, reflecting minimal growth, with notable annual variations including a 9.21% decrease in 2022 and a marginal 0.12% decrease in 2023.
Future trends to watch for:
- Potential innovations and demand shifts in antibiotic resistance management.
- Public health initiatives and government policies impacting market growth.
- Import-export changes affecting supply chains in Central America.
How does Nicaragua rank in Penicillins and Streptomycins in Dosage Market Size Value?
| # | 33 Countries | US Dollars | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 United States | 4,303,400,000 | 2023 | +0.61% | +1.48% | View data |
| 2 | 2 United Kingdom | 730,000,000 | 2023 | -1.31% | -1.45% | View data |
| 3 | 3 France | 717,200,000 | 2023 | -1.91% | +0.034% | View data |
| 4 | 4 Italy | 622,330,000 | 2023 | -3.96% | -4.86% | View data |
| 5 | 5 Germany | 476,270,000 | 2023 | +1.03% | +1.1% | View data |
| 26 | 26 Morocco | 20,047,000 | 2023 | -0.6% | -1.22% | View data |
| 27 | 27 Ghana | 19,904,000 | 2023 | +0.28% | -1.55% | View data |
| 28 | 28 Nicaragua | 15,976,000 | 2023 | -0.12% | +0.75% | |
| 29 | 29 Kyrgyzstan | 10,516,000 | 2023 | -0.4% | -0.84% | View data |
| 30 | 30 Moldova | 5,776,600 | 2023 | -4.38% | -6.74% | View data |
